Llorens et al. (2017a) comparatively analyzed YKL-40 levels in the brain and CSF samples from AD patients, vascular dementia patients, dementia with Lewy bodies/Parkinson’s disease, and sporadic CJD, then compared them with the control individuals [23]. This evidence concerns the gene CHI3L1 and Parkinson disease.